Literature DB >> 861592

Comparative study of alkaline phosphatase isoenzymes, bone histology, and skeletal radiography in dialysis bone disease.

R B Naik, P Gosling, C P Price.   

Abstract

Liver, intestinal, and bone alkaline phosphatase isoenzymes were measured using heat stability and L-phenylalanine inhibition techniques in 78 patients on intermittent haemodialysis. Fifty-five patients had abnormalities in one or more of the isoenzymes. Changes in bone and intestinal alkaline phosphatase activities seemed to be related and raised liver isoenzyme activity was associated with the development of liver disease. Abnormal histological and radiological findings were better correlated with bone alkaline phosphatase levels than with total alkaline phosphatase, and serial estimations of bone isoenzyme activity were useful in assessing the response of renal osteodystrophy to treatment with a vitamin D analogue. Serum alkaline phosphatase isoenzyme measurement provides another useful and non-invasive index for monitoring metabolic bone disease in patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861592      PMCID: PMC1607206          DOI: 10.1136/bmj.1.6072.1307

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  Comparison of biochemical with radiological findings in renal osteodystrophy.

Authors:  J F Moorhead; Z Varghese; G L Tatler; R A Baillod; M R Wills
Journal:  Ann Clin Biochem       Date:  1975-05       Impact factor: 2.057

Review 2.  Radiological patterns of bone disease associated with renal glomerular failure in adults.

Authors:  F H Doyle
Journal:  Br Med Bull       Date:  1972-09       Impact factor: 4.291

3.  A study of various electrophoretic and inhibition techniques for separating serum alkaline phosphatase isoenzymes.

Authors:  R B Johnson; K Ellingboe; P Gibbs
Journal:  Clin Chem       Date:  1972-02       Impact factor: 8.327

4.  [Serum alkaline phosphatase as indicator of the liver and bone involvement in patients treated by chronic dialysis].

Authors:  J Stĕpán; T Pilarová; O Votrubová; D Melicharová
Journal:  Cas Lek Cesk       Date:  1974-08-02

5.  Letter: Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis.

Authors:  M E De Broe; V Bosteels; R J Wieme
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

6.  Serum alkaline phosphatase: total activity and isoenzyme determinations made by use of the centrifugal fast analyzer.

Authors:  B E Statland; H H Nishi; D S Young
Journal:  Clin Chem       Date:  1972-12       Impact factor: 8.327

7.  The diversity of alkaline phosphatase from rat intestine. Isolation and purification of the enzyme (s).

Authors:  P K Saini; J Done
Journal:  Biochim Biophys Acta       Date:  1972-01-20

8.  Liver disease in patients treated with chronic hemodialysis.

Authors:  K J Ivey; J A Clifton
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

9.  Liver impairment during chronic hemodialysis and after renal transplantation.

Authors:  V Nielsen; E Clausen; L Ranek
Journal:  Acta Med Scand       Date:  1975-03

10.  Increased incidence of malignancy during chronic renal failure.

Authors:  A J Matas; R L Simmons; C M Kjellstrand; T J Buselmeier; J S Najarian
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

View more
  3 in total

Review 1.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

2.  Correlative factors of left ventricular hypertrophy in end-stage renal disease.

Authors:  Y Dai; S J He; Y Yu; L Y Zhu; B Peng; J B Liu; S C Tang
Journal:  J Tongji Med Univ       Date:  1993

3.  Relationships between radiological and biochemical evidence of rickets in Asian schoolchildren.

Authors:  A Abdul-Motaal; G Gettinby; W B McIntosh; G R Sutherland; M G Dunnigan
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.